Plante Moran Financial Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Plante Moran Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$107.32 - $113.5 $27,259 - $28,829	254 Added 453.57%	310 $33,000
Q4 2022 Feb 09, 2023	SELL	$62.39 - $113.8 $35,000 - $63,841	-561 Reduced 90.92%	56 $6,000
Q3 2022 Nov 02, 2022	BUY	$58.92 - $84.67 $21,505 - $30,904	365 Added 144.84%	617 $38,000
Q2 2022 Aug 02, 2022	BUY	$79.4 - $116.36 $2,064 - $3,025	26 Added 11.5%	252 $20,000
Q1 2022 May 06, 2022	BUY	$86.42 - $109.81 $14,691 - $18,667	170 Added 303.57%	226 $24,000

Q3 2021 Nov 08, 2021	SELL	$91.91 - $110.37 $25,642 - $30,793	-279 Reduced 83.28%	56 $6,000
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $17,248 - $19,184	200 Added 148.15%	335 $31,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $4,022 - $5,346	-56 Reduced 29.32%	135 $12,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $3,092 - $4,476	56 Added 41.48%	191 $15,000
Q1 2020 May 07, 2020	BUY	$24.87 - $38.56 $3,357 - $5,205	135 New	135 $4,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.